HPTN 065 TLC-Plus: Feasibility of an enhanced test, link-to- care plus treat approach for HIV prevention in the U.S. HIV Research Catalyst Forum April.

Slides:



Advertisements
Similar presentations
HIV/AIDS in Ethiopia Daniel Yilma Jimma Univeristy, Ethiopia.
Advertisements

Kessler, J. Myers, J.E. ; Nucifora, K.A. ; Mensah, N. ; Kowalski, A. ; Sweeney, M. ; Toohey, C. ; Shepard, C. ; Cutler, B. ; Braithwaite, R.S. Modeling.
Delphine Sculier, MD,MPH Stop TB Department World Health Organisation Geneva, Switzerland Update on the revision of ART guidelines for TB patients.
February Dakar, Senegal
Sexually Transmitted Diseases Among Men Who Have Sex with Men: A need for new prevention and research strategies National Sexually Transmitted Disease.
State of Texas HIV Planning &. Goals for the National HIV/AIDS Strategy 1.Reduce new HIV infections 2.Increase access to care and improve health outcomes.
A.Toni Young. CEG targets Wards 6, 7 & 8 community aiming to increase: HIV testing; HCV testing; Knowledge about HIV/AIDS, HCV, S.A; Utilization of HIV/HCV.
Integration with ART for HIV+ Heterosexual men Risk of Resistance MSM High-risk women Young MSM of color Transgender women Long-term safety Provider attitudes.
United States Rural vs. Non-Rural HIV Care Continuum Differences April 17, 2015 AETC Program Rural Health Committee (Alyssa Bittenbender, Terri Bramel,
TasP is not enough Stipulated that TasP is effective in reducing infectiousness of the treated person – But much more is required. TasP requires effective.
Are people living with HIV less likely to pass HIV to others if they are on treatment? Exploring the use of treatment as prevention James Wilton Project.
STI Prevention & Control Programs Local and State M. Terry Hogan, MPH STD/HIV Prevention Training Center at JH June 9, 2014 National Center for HIV/AIDS,
Positive Living Navajo AIDS Network, Inc. Melvin Harrison, Executive Director Marco Arviso, Arizona Medical Case Manager.
Treatment as prevention: a new paradigm for HIV control? Richard Hayes.
2 AMERIGROUP Community Care Entered Maryland market in 1999 Largest MCO in Maryland Serving over 143,000 members in Baltimore City and 20 counties in.
Community Feedback and Involvement in [Health Department’s] Proposed Data to Care Program [Name of Provider Session Date of Provider Session]
F/C AETC Faculty HIV HCV Thursday, March 12, 2015 | 1:30pm EDT Medical Facilitator/Didactic Presenter Todd S. Wills, MD University of South Florida Case.
Morbidity Monitoring Project Data for Resource Planning and Evaluation A.D. McNaghten Centers for Disease Control and Prevention.
Larry Cuellar Adult Viral Hepatitis Prevention Coordinator Texas Department of State Health Services 2010 STREET OUTREACH WORKERS CONFERENCE June 21, 2010.
Dr Johann Sheehan ACT Health Directorate September 2012.
Context and Rationale for Pay for Performance in SUD Treatment NIATx-SI State Call April 2010.
2012 Connecticut Community Readiness Assessment for Substance Use Prevention: ERASE Strategic Prevention Framework University of Connecticut Health Center.
Using HIV Surveillance to Achieve High Impact Prevention Irene Hall, PhD, FACE AIDS 2012 High-Impact Prevention: Reducing the HIV Epidemic in the United.
Joan Holloway Vice President, Global Health Initiatives Multidisciplinary Care Team Delivery of Integrated HIV Services.
A Look Back at 2010 HIV/AIDS Research (Part 2) Expert Commentary A Clinical Context Report.
ART for Prevention From Evidence to Action Wafaa El-Sadr, MD, MPH ICAP-Columbia University.
Myron S. Cohen, MD Associate Vice Chancellor Director, Institute for Global Health The University of North Carolina.
JORDAN E. LAKE, MD, MSC AAHU SEPTEMBER 2014 Prevention for Positives.
Positive Living Navajo AIDS Network, Inc. Melvin Harrison, Executive Director Marco Arviso, Arizona Medical Case Manager.
Monitoring &Evaluation System in Health Program. Brief overview of NACP Reporting units and quality aspects Data sets Learning/ Analysis of the data sets.
UNITED STATES CONFERENCE ON AIDS MONDAY, SEPTEMBER 9, 2013 NEW ORLEANS, LA Will Community Involvement in Test Link to Care, Plus Treat Research (HPTN 065)
TREATMENT OF SERO-DISCORDANT COUPLES: IMPLICATIONS FOR YOUNG PEOPLE JJ KUMWENDA (FRCP-UK)
HIV-infected subjects with CD4 350 to 550 cells/mm serodiscordant couples HPTN 052 Study Design Immediate ART CD Delayed ART CD4
STATE OF THE STATE SHELLEY LUCAS HIV/STD PREVENTION & CARE BRANCH DEPT OF STATE HEALTH SERVICES AUGUST 3, 2015.
The WHO HIV Drug Resistance Strategy Presented by Dr. Don Sutherland Prepared by: Dr. Don Sutherland Dr Silvia Bertagnolio Dr Diane Bennett HIV Drug Resistance.
ZIMBABWE AIDS CARE FOUNDATION NEWLANDS CLINIC Virological Outcomes in Adult Patients on Second Line ART, at Newlands Clinic Dr S. Bote.
Community Plan Implementation Training 1-1. Community Plan Implementation Training 1-1 Community Plan Implementation Training 1-2.
Care Packages in Substance Misuse Treatment Development of MH Care Clusters: overview  Service users in MH, clinicians found: idiosyncratic referral pathways.
Ryan White All Grantees Meeting Washington, DC November, 2012 Supporting National HIV/AIDS Strategies: the domestic experience and the AETCs.
Evaluating the Use of HIV Surveillance Data for Initiating Partner Services in Houston, Texas, US 2012 International AIDS Conference Washington, D.C. Shirley.
Understanding temporal trends in HIV prevalence, incidence and ARV Dr Valerie Delpech Head of HIV surveillance Public Health England.
HIV and STI Department, Health Protection Agency - Colindale HIV and AIDS Reporting System The threshold for an ART secondary prevention effect on HIV.
Mobile telemedicine for Community Health Worker HIV Care: A pilot study in Nairobi, Kenya Jennifer Cohn, MD MPH University of Pennsylvania School of Medicine.
JORDAN E. LAKE, MD, MSC AAHU AUGUST 2015 Prevention for Positives.
Evaluation Plan Steven Clauser, PhD Chief, Outcomes Research Branch Applied Research Program Division of Cancer Control and Population Sciences NCCCP Launch.
ENLACES POR LA SALUD UNC CHAPEL HILL. HIV CASCADE OF CARE, NC.
PMTCT - The Platform for integrating HIV/AIDS Services in the MCH Clinic. Bola Oyeledun, MD, MPH Track 1.0 Partners Meeting Washington DC. August 2008.
N ORTHWEST AIDS E DUCATION AND T RAINING C ENTER HIV Prevention in Clinical Care Settings Jeanne Marrazzo, MD, MPH Professor, Division of Allergy and Infectious.
Henry Masur, MD Bethesda, Maryland
Case Management Training Program May 18, 2016 Anissa Ray, Training Program Manager, Infectious Disease Bureau Vadim Kogan Training Coordinator, Infectious.
Integrating Program Innovation to Improve Prevention and Care Services USCA 2016 – September 17, 2016 April Stubbs-Smith, MPH Director, Division of Domestic.
HPTN 071 (PopART): Have we reached the targets after two years of the PopART intervention IAS Paris July 2017 Richard Hayes.
State Office of AIDS Update
Module 4: Engaging KPs with HIV and SRH Services
Kathleen Brady, MD; Coleman Terrell; Marlene Matosky, MPH, RN
Addressing the Intersection of Substance Abuse and Viral Hepatitis
Entry into care Failure to initiate timely HIV care after diagnosis is common ~75% of newly diagnosed link to care within 6-12 months Delayed entry into.
Patient Navigation Program
CIIS Implementation in Progress Mari-Lynn Drainoni, PhD, MEd
Continuum of HIV Care, Treatment, and Prevention
Richard hayes London school of hygiene & Tropical Medicine
A Count We Still Count on
Double-sided HIV Cascades for Key Populations
Chloe Orkin British HIV Association Queen Mary University London
Developing and Using a Referral Network
Dianne Rausch, Ph.D. Director, Division of AIDS Research
Needs Assessment Slides for Module 4
Serum Vitamin C (mg/dl) by Salad Intake
Prism Health North Texas Programs and Services
Robert H. Remien, Co-Chair
Presentation transcript:

HPTN 065 TLC-Plus: Feasibility of an enhanced test, link-to- care plus treat approach for HIV prevention in the U.S. HIV Research Catalyst Forum April 21, 2010, Baltimore, MD A. Toni Young Executive Director Community Education Group

TLC+ Test and Treat enough HIV+ people Granich et al, 2009 Decrease in HIV Transmission Granich et al, 2009

High uptake of annual testing by all >15 year old individuals All HIV+ individuals start ART immediately, irrespective of stage of HIV disease 99% decrease in infectiousness High adherence with ART Low failure with first line ART Model Assumptions

Study Communities Intervention communities ◦Washington DC ◦Bronx, NY Comparison communities ◦Houston ◦Philadelphia ◦Chicago ◦Miami

Study Objectives and Outcomes Assesses feasibility and effectiveness outcomes, dependent on study component Assesses the feasibility of using surveillance data for outcomes All aim at determining feasibility of overall strategy TLC-Plus is not designed to measure a change in HIV incidence

TLC+ 065 Protocol Overview PURPOSE To evaluate the feasibility of an enhanced community-level HIV test, link-to-care plus treat strategy in the U.S.

Study Objectives and Outcomes Assesses feasibility and effectiveness outcomes, dependent on study component Assesses the feasibility of using surveillance data for outcomes All aim at determining feasibility of overall strategy TLC-Plus is not designed to measure a change in HIV incidence

Study Duration

Key Issues Addressed Financial incentives ◦Plans to minimize the risk of overuse of financial incentives ◦Address risk of migration from sites randomized to different interventions Provider training ◦Supportive services for PLWH (mental health, substance use, adherence support) ◦Mapping of resources in the communities ◦Use of ART for achievement of maximal viral suppression Timeliness and quality of surveillance data

Expanded HIV Testing Social mobilization Universal offer of testing in ED/hospital admissions Test Linkage-to- Care Provider Training Linkage to services [ SA, MH] HIV prevention counseling Maximize ART initiation per current guidelines Provider & Patient Surveys Knowledge & attitudes regarding ART & FIs Initiate/Continue ART per current guidelines Viral Suppression Linkage-to-Care Randomization of HIV Test Sites FI to link to care SOC to link to care Prevention for Positives Randomization of HIV+ Patients CARE plus SOC SOC alone Viral Suppression Randomization of HIV Care Sites FI for viral suppression SOC for viral suppression What Will the Study Entail

Thank You To HPTN and FHI for Use of Slides A. Toni Young 3233 Pennsylvania Avenue, SE Washington, DC,